Please provide your email address to receive an email when new articles are posted on . Relative risk for breast cancer rises about 20% to 30% with recent use of any oral contraceptives. Current or ...

As much as they may be a small nuisance to take every day, oral contraceptives — that’s the pill — are here to stay (at least until better, longer-term, and more convenient birth control options come ...

A new analysis involving almost 10,000 women has shown that the added risk of breast cancer occurring under the age of 50 in association with oral contraceptive use was of similar magnitude regardless ...

Studies have suggested for decades that birth control pills containing both estrogen and progestogen — synthetic versions of female hormones — may slightly elevate one’s risk of breast cancer. But ...

New research has found that all hormonal contraceptives “carry a small increased risk of breast cancer,” The Guardian reports. Previously only the combined pill was linked to an increased risk of ...

Many women are taking progestin-only contraceptives, whose association with breast cancer risk isn’t well-known. A new study says that the risk associated with progestin-only pills is broadly in line ...

NEW YORK--(BUSINESS WIRE)--The Perrigo launch of their FDA approved OTC Opill is great news for women in the U.S. who rely on progesterone-only birth control pills for their contraception.

The FDA announced yesterday that it had for the first time approved a daily birth-control pill for over-the-counter sales. That’s a big change; once the product, called Opill, is on the market—which ...

Please provide your email address to receive an email when new articles are posted on . Combined oral contraceptive use was not linked to asthma attacks. The link between progestogen-only pill use and ...